文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛心脑血管急症

COVID-19的非呼吸系统表现:临床综述

Non-respiratory presentations of COVID-19, a clinical review.
PubMed 文献 · Am J Emerg Med · 2020-09-24
一句话结论COVID-19除呼吸道症状外,还可出现血液、消化、肾脏、皮肤及神经精神等多系统表现,认识这些表现有助于快速诊断、治疗和隔离。

本文是一篇临床综述,系统总结了COVID-19的血液学、胃肠病学、肾脏、皮肤、神经及精神系统表现。血液学异常包括淋巴细胞计数降低、凝血酶原时间延长、D-二聚体升高和乳酸脱氢酶升高,其中部分与死亡率增加相关。胃肠症状以恶心、呕吐、腹泻和腹痛最常见,患者粪便中检出病毒RNA提示可能增加检测途径。肾脏表现包括蛋白尿、血尿及尿素氮和肌酐升高,合并急性肾损伤的患者死亡风险更高。皮肤表现包括红斑疹、荨麻疹和水痘样皮损,神经精神表现包括病毒性脑炎、脑血管病、周围神经病变和精神病的相关表现。

要点

  • COVID-19患者出现淋巴细胞计数降低、凝血酶原时间延长、D-二聚体升高和乳酸脱氢酶升高时,部分指标与死亡率增加相关。
  • COVID-19合并急性肾损伤的患者死亡风险更高。
  • COVID-19患者粪便中检出病毒RNA,提示可能存在额外的检测途径。
  • COVID-19的肺外表现多样且不可预测,包括皮肤红斑疹、荨麻疹和水痘样皮损,以及神经精神症状。
  • 认识COVID-19的非呼吸系统表现可促进更高效的诊断、快速治疗、隔离和减少疾病传播。

适用人群与场景

  • COVID-19患者,包括以肺外表现就诊或住院者;原文未明确排除人群。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • COVID-19患者出现急性肾损伤时死亡风险更高。
  • COVID-19患者出现病毒性脑炎、脑血管病、周围神经病变或精神病相关表现。
  • COVID-19患者出现淋巴细胞计数降低、凝血酶原时间延长、D-二聚体升高或乳酸脱氢酶升高,其中部分与死亡率增加相关。

研究设计与关键结果

  • 本文为临床综述,总结了COVID-19的血液学、胃肠病学、肾脏、皮肤、神经及精神系统表现。
  • 血液学异常包括总淋巴细胞计数降低、凝血酶原时间延长、D-二聚体升高和乳酸脱氢酶升高,部分与死亡率增加相关。
  • 胃肠症状以恶心、呕吐、腹泻和腹痛最常见,粪便中检出病毒RNA提示可能存在额外检测途径。
  • 肾脏表现包括蛋白尿、血尿及尿素氮和肌酐升高,合并急性肾损伤的患者死亡风险更高。
  • 皮肤表现包括红斑疹、荨麻疹和水痘样皮损。
  • 神经精神表现包括病毒性脑炎、脑血管病、周围神经病变和精神病的相关表现。

证据类型、等级与局限

  • 证据类型:综述。
  • 原文未述局限性。

对床旁实践的改变

  • 对COVID-19患者应关注肺外表现,包括血液学异常、胃肠症状、肾脏损伤、皮肤病变及神经精神症状,以促进更高效的诊断、快速治疗、隔离和减少传播。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) is a highly infectious viral syndrome currently threatening millions of people worldwide. It is widely recognized as a disease of the pulmonary system, presenting with fever, cough, and shortness of breath. However, a number of extrapulmonary manifestations have been described in the literature.

OBJECTIVE: In this review, we seek to provide a comprehensive summary of the hematologic, gastroenterological, renal, dermatologic, neurologic, and psychiatric manifestations of COVID-19.

DISCUSSION: Hematological presentations of COVID-19 include laboratory abnormalities such as decreased total lymphocyte count, prolonged prothrombin time (PT), elevated d-dimer, and increased lactate dehydrogenase (LDH). Several of these findings are associated with increased mortality among infected patients. The most common gastrointestinal symptoms include nausea, vomiting, diarrhea, and abdominal pain. Furthermore, presence of viral RNA in patient stool suggests the possibility of additional testing modalities for COVID-19. Nephrological findings such as proteinuria, hematuria, and elevated BUN and creatinine levels have been observed. Additionally, several studies demonstrated that patients with COVID-19 who developed acute kidney injury (AKI) had a greater risk of mortality. The virus can also present with cutaneous symptoms such as erythematous rashes, urticaria, and chicken pox-like lesions. Neuropsychiatric symptoms have been described in the literature, and patients can exhibit findings consistent with viral encephalitis, cerebral vascular disease, peripheral nerve disorders, and psychosis.

CONCLUSION: Although COVID-19 does usually present primarily with respiratory symptoms, the extra-pulmonary manifestations of the virus are unpredictable and varied. Better understanding and awareness of these symptoms can lead to more efficient diagnosis, rapid treatment, isolation, and decreased spread of the disease.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. AlSamman M, Caggiula A, Ganguli S, et al. Non-respiratory presentations of COVID-19, a clinical review. Am J Emerg Med. 2020. PMID: 33039218. doi:10.1016/j.ajem.2020.09.054

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。